Pacific Biosciences of California, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.32 | -$0.26 | -$0.28 |
| Q2 2024 | 1 | -$0.27 | -$0.22 | -$0.23 |
| Q3 2024 | 2 | -$0.26 | -$0.20 | -$0.22 |
| Q4 2024 | 7 | -$0.29 | -$0.16 | -$0.21 |
| Q1 2025 | 5 | -$0.25 | -$0.15 | -$0.19 |
| Q2 2025 | 4 | -$0.21 | -$0.17 | -$0.18 |
| Q3 2025 | 4 | -$0.20 | -$0.16 | -$0.17 |
| Q4 2025 | 4 | -$0.21 | -$0.16 | -$0.18 |
| Q1 2026 | 3 | -$0.21 | -$0.17 | -$0.18 |
| Q2 2026 | 3 | -$0.21 | -$0.16 | -$0.17 |
| Q3 2026 | 3 | -$0.16 | -$0.13 | -$0.14 |
| Q4 2026 | 3 | -$0.20 | -$0.16 | -$0.17 |
Pacific Biosciences of California, Inc. Earnings Date And Information
Pacific Biosciences of California, Inc. last posted its earnings results on Thursday, November 7th, 2024. The company reported $-0.17 earnings per share for the quarter, topping analysts' consensus estimates of $-0.2 by $0.03. The company had revenue of 39.97 M for the quarter and had revenue of 200.52 M for the year. Pacific Biosciences of California, Inc. has generated $-1 earnings per share over the last year ($-1.21 diluted earnings per share) and currently has a price-to-earnings ratio of -1.23. Pacific Biosciences of California, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 13th, 2025 based on prior year's report dates.
Pacific Biosciences of California, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/08/2024 | Q3 2024 | -$0.22 | $41.95 M | $39.97 M | ||
| 08/08/2024 | Q2 2024 | -$0.64 | $40.88 M | $36.01 M | ||
| 05/09/2024 | Q1 2024 | -$0.26 | -$0.29 | -0.03 | $38.81 M | |
| 12/30/2023 | Q4 2023 | -$0.31 | $58.36 M | |||
| 11/03/2023 | Q3 2023 | -$0.26 | $48.76 M | $55.69 M | ||
| 08/04/2023 | Q2 2023 | -$0.28 | $40.18 M | $47.57 M | ||
| 05/04/2023 | Q1 2023 | -$0.34 | $38.90 M | |||
| 02/28/2023 | Q4 2022 | -$0.35 | $27.35 M | |||
| 11/08/2022 | Q3 2022 | -$0.37 | $35.40 M | $32.31 M | ||
| 08/05/2022 | Q2 2022 | -$0.32 | $35.16 M | $35.47 M | ||
| 05/05/2022 | Q1 2022 | -$0.38 | $33.17 M | |||
| 02/28/2022 | Q4 2021 | -$0.32 | $36.02 M | |||
| 11/04/2021 | Q3 2021 | $0.08 | $33.60 M | $34.89 M | ||
| 08/05/2021 | Q2 2021 | -$0.21 | $29.99 M | $30.61 M | ||
| 05/06/2021 | Q1 2021 | -$0.45 | $29.00 M | |||
| 02/26/2021 | Q4 2020 | $0.40 | $27.14 M | |||
| 11/02/2020 | Q3 2020 | -$0.14 | $20.33 M | $19.08 M | ||
| 08/06/2020 | Q2 2020 | -$0.15 | $13.72 M | $17.08 M | ||
| 05/08/2020 | Q1 2020 | $0.01 | $15.60 M | |||
| 02/28/2020 | Q4 2019 | -$0.00 | $27.93 M |
Pacific Biosciences of California, Inc. Earnings: Frequently Asked Questions
-
When is Pacific Biosciences of California, Inc.'s earnings date?
Pacific Biosciences of California, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 13th, 2025 based off last year's report dates.
-
Did Pacific Biosciences of California, Inc. beat their earnings estimates last quarter?
In the previous quarter, Pacific Biosciences of California, Inc. (:PACB) reported $-0.17 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.2 by $0.03.
-
How can I listen to Pacific Biosciences of California, Inc.'s earnings conference call?
The conference call for Pacific Biosciences of California, Inc.'s latest earnings report can be listened to online.
-
How can I read Pacific Biosciences of California, Inc.'s conference call transcript?
The conference call transcript for Pacific Biosciences of California, Inc.'s latest earnings report can be read online.
-
How much revenue does Pacific Biosciences of California, Inc. generate each year?
Pacific Biosciences of California, Inc. (:PACB) has a recorded annual revenue of $200.52 M.
-
How much profit does Pacific Biosciences of California, Inc. generate each year?
Pacific Biosciences of California, Inc. (:PACB) has a recorded net income of $200.52 M. Pacific Biosciences of California, Inc. has generated $-1.21 earnings per share over the last four quarters.
-
What is Pacific Biosciences of California, Inc.'s price-to-earnings ratio?
Pacific Biosciences of California, Inc. (:PACB) has a price-to-earnings ratio of -1.23 and price/earnings-to-growth ratio is -0.46.
